The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis.

Bayón, J C; Orruño, E; Portillo, M I; Asua, J

Bayón, J C; Orruño, E; Portillo, M I; Asua, J.

Afiliação

Bayón JC; 1Basque Office for Health Technology Assessment (OSTEBA), Ministry of Health, Basque Government, c/Donostia 1, 01010 Vitoria-Gasteiz, Basque Country Spain.
Orruño E; Bioaraba Health Research Institute, Methodology and Statistics Unit, Araba University Hospital, Txagorritxu Headquarters, 4th Floor, c/José Achótegui, 01009 Vitoria-Gasteiz, Basque Country Spain.
Portillo MI; Colorectal and Prenatal Screening Coordinating Centre, Basque Health Service, Bilbao, Basque Country Spain.
Asua J; 1Basque Office for Health Technology Assessment (OSTEBA), Ministry of Health, Basque Government, c/Donostia 1, 01010 Vitoria-Gasteiz, Basque Country Spain.

Cost Eff Resour Alloc ; 17: 6, 2019.

Article em En | MEDLINE | ID: mdl-30867656

Palavras-chave

Cost-effectiveness analysis; Down syndrome; NIPT, non-invasive prenatal testing; Prenatal screening; Trisomy 21; cffDNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Evaluation_studies / Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google